+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biological & Medical Imaging Reagents Market - Global Forecast 2026-2032- Product Image
Biological & Medical Imaging Reagents Market - Global Forecast 2026-2032- Product Image
Sale

Biological & Medical Imaging Reagents Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6280648
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biological & Medical Imaging Reagents: Executive Overview

Biological and medical imaging reagents enable visualization, detection, labeling, and characterization across preclinical research, clinical diagnostics, pathology, molecular imaging, and drug development. The field spans contrast agents, fluorescent probes, radionuclide-linked compounds, antibodies, dyes, stains, and assay reagents. Demand is shaped by the need for earlier diagnosis, higher analytical specificity, reproducible workflows, and compatibility with increasingly automated imaging systems.

How Imaging Reagents Are Transforming Research and Diagnosis

The landscape is shifting from conventional contrast and staining workflows toward more targeted, multiplexed, and quantitative approaches. Researchers and clinicians increasingly seek reagents that bind specific biomarkers, support simultaneous detection of multiple signals, and integrate with digital pathology, high-content screening, and advanced microscopy. Regulatory scrutiny, lot-to-lot consistency, cold-chain requirements, and validation standards remain important adoption considerations, while automation is improving throughput and repeatability.

Artificial Intelligence Is Increasing the Value of High-Quality Imaging Data

Artificial intelligence is influencing reagent development and use by enabling automated image segmentation, feature extraction, classification, quality control, and longitudinal interpretation. These tools increase the value of standardized, high-contrast, and multiplexed images, creating stronger incentives for reagents that produce consistent signal intensity and low background noise. However, algorithmic performance depends on representative training data, harmonized imaging protocols, transparent validation, and careful management of artifacts caused by reagent variability.

Regional Insights Across the Global Imaging Reagents Landscape

North America is characterized by advanced biomedical research, sophisticated clinical imaging infrastructure, and strong adoption of digital and molecular workflows. Europe combines established translational research capabilities with stringent quality and regulatory expectations, while the European Union benefits from cross-border research collaboration alongside varied national procurement systems. Asia-Pacific is supported by expanding diagnostic capacity, biopharmaceutical research, and investment in laboratory automation, with adoption patterns differing across developed and emerging markets. Latin America is shaped by uneven access to advanced imaging platforms, local research centers, and import and distribution constraints. The Middle East is developing specialized healthcare and research capacity, particularly in major urban systems, while Africa continues to face infrastructure, affordability, supply-chain, and workforce challenges that influence reagent availability and utilization.

Group-Level Priorities Shape Adoption and Collaboration

ASEAN markets show varied maturity, with regional integration and growing laboratory capacity supporting broader access while regulatory and procurement practices remain diverse. BRICS members combine substantial research and healthcare capabilities with differences in infrastructure, domestic manufacturing, and reimbursement conditions. The European Union emphasizes quality systems, data governance, cross-border research, and regulatory alignment. G7 countries generally prioritize advanced diagnostics, translational science, laboratory automation, and stringent product validation. GCC countries are investing in specialized healthcare infrastructure and research capacity, with procurement and localization increasingly important. NATO members reflect diverse national systems but share interest in resilient medical supply chains, interoperability, and preparedness for biological and public-health threats.

Country-Level Conditions Affect Reagent Development and Use

Australia combines strong biomedical research with a geographically dispersed healthcare system. Brazil has major research and clinical centers, alongside regional disparities and import sensitivity. Canada benefits from established research institutions and public healthcare networks. China is expanding domestic research, diagnostics, and manufacturing capabilities. France, Germany, Italy, Spain, and the United Kingdom maintain significant academic, hospital, and life-science ecosystems, with national differences in reimbursement, procurement, and regulatory implementation. India is developing broad diagnostic and research capacity while addressing affordability and infrastructure variation. Japan emphasizes precision, quality, and advanced laboratory technologies. Mexico is strengthening diagnostic services but continues to experience differences between major centers and underserved regions. Russia has established scientific capabilities alongside constraints related to procurement, technology access, and international supply channels. South Korea combines advanced electronics, biotechnology, and healthcare infrastructure with strong interest in automated and digitally integrated workflows. The United States remains a major center for biomedical innovation, clinical research, and adoption of advanced imaging technologies.

Strategic Priorities for Imaging Reagent Industry Leaders

Leaders should prioritize reproducible performance, transparent validation, and compatibility with the imaging platforms used by target laboratories and healthcare systems. Product development should focus on clinically meaningful specificity, multiplexing, low background, stable formulation, and simplified handling, while quality teams should strengthen lot release, reference standards, and traceability. Commercial strategies should account for regional regulatory pathways, cold-chain realities, public procurement, and local technical support. Partnerships with hospitals, research institutions, imaging-platform developers, and diagnostic laboratories can improve workflow integration. Organizations should also prepare datasets and labeling practices that support responsible AI use, with explicit controls for bias, privacy, interpretability, and human oversight.

Research Methodology for the Executive Summary

This summary uses a structured qualitative review of the biological and medical imaging reagents landscape, organized by application context, reagent function, technology shift, geography, economic grouping, and country environment. The assessment considers documented developments in imaging science, laboratory automation, molecular diagnostics, digital pathology, artificial intelligence, regulation, healthcare infrastructure, and supply-chain conditions. Regional and country observations are comparative rather than quantitative and are intended to identify operating conditions, adoption drivers, barriers, and strategic priorities without presenting market estimates, shares, forecasts, or company-specific claims.

Conclusion: Building Reliable, Intelligent Imaging Workflows

Biological and medical imaging reagents are becoming more central to precise, quantitative, and digitally connected research and diagnostic workflows. The strongest opportunities are associated with targeted detection, multiplexed analysis, automation, and AI-assisted interpretation, but progress depends on dependable reagent quality, validated protocols, resilient supply, and equitable access to enabling infrastructure. Industry leaders that combine scientific performance with regulatory discipline, workflow interoperability, regional responsiveness, and responsible data practices will be better positioned to support the next generation of imaging applications.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biological & Medical Imaging Reagents Market, by Product Type
7.1. Introduction
7.2. Calibration And Reference Standards
7.3. Contrast Agents
7.4. Imaging Agents
7.5. Kits And Assay Reagents
7.6. Labeling Reagents
7.7. Nanomaterials
8. Biological & Medical Imaging Reagents Market, by Imaging Modality
8.1. Introduction
8.2. Computed Tomography
8.3. Magnetic Resonance Imaging
8.4. Nuclear
8.5. Photoacoustic
9. Biological & Medical Imaging Reagents Market, by Target Type
9.1. Introduction
9.2. Cellular Targets
9.3. Molecular Targets
9.4. Tissue And Organ Targets
10. Biological & Medical Imaging Reagents Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.3. Companion Diagnostics
10.4. Drug Discovery And Development
10.5. Image Guided Surgery
11. Biological & Medical Imaging Reagents Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Biological & Medical Imaging Reagents Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Biological & Medical Imaging Reagents Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Agilent Technologies, Inc.
15.2. Bayer AG
15.3. Bio-Rad Laboratories, Inc.
15.4. Bracco Imaging S.p.A.
15.5. Cardinal Health, Inc.
15.6. Curium Pharma
15.7. FUJIFILM Holdings Corporation
15.8. GE HealthCare Technologies Inc.
15.9. Guerbet Group
15.10. Jubilant Radiopharma Limited
15.11. Lantheus Holdings, Inc.
15.12. Mallinckrodt Pharmaceuticals
15.13. Merck KGaA
15.14. PerkinElmer, Inc.
15.15. Siemens Healthineers AG
15.16. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biological & Medical Imaging Reagents Market, Years Considered for the Study
FIGURE 2. Global Biological & Medical Imaging Reagents Market, Research Design
FIGURE 3. Global Biological & Medical Imaging Reagents Market, Research Framework
FIGURE 4. Global Biological & Medical Imaging Reagents Market, Data Triangulation
FIGURE 5. Global Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biological & Medical Imaging Reagents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Biological & Medical Imaging Reagents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2025 vs 2032 (%)
FIGURE 9. Global Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biological & Medical Imaging Reagents Market Size, by Target Type, 2025 vs 2032 (%)
FIGURE 11. Global Biological & Medical Imaging Reagents Market Size, by Target Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biological & Medical Imaging Reagents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Biological & Medical Imaging Reagents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biological & Medical Imaging Reagents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Biological & Medical Imaging Reagents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biological & Medical Imaging Reagents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Biological & Medical Imaging Reagents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Biological & Medical Imaging Reagents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biological & Medical Imaging Reagents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biological & Medical Imaging Reagents Market Segmentation & Coverage
TABLE 2. Global Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Calibration And Reference Standards Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Calibration And Reference Standards Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Calibration And Reference Standards Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Imaging Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Kits And Assay Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Kits And Assay Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Kits And Assay Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Labeling Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Labeling Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Labeling Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Nanomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Nanomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Nanomaterials Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 23. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Magnetic Resonance Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Magnetic Resonance Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Magnetic Resonance Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Nuclear Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Nuclear Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Nuclear Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Photoacoustic Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Photoacoustic Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Photoacoustic Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 36. Global Cellular Targets Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Cellular Targets Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Cellular Targets Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Molecular Targets Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Molecular Targets Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Molecular Targets Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Tissue And Organ Targets Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Tissue And Organ Targets Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Tissue And Organ Targets Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Companion Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Companion Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Companion Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Drug Discovery And Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Drug Discovery And Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Drug Discovery And Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Image Guided Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Image Guided Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Image Guided Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Biological & Medical Imaging Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Biological & Medical Imaging Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. North America Biological & Medical Imaging Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. North America Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 66. North America Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 67. North America Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 68. North America Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. Latin America Biological & Medical Imaging Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Latin America Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 71. Latin America Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 72. Latin America Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 73. Latin America Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. Europe Biological & Medical Imaging Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Europe Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. Europe Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 77. Europe Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 78. Europe Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. Middle East Biological & Medical Imaging Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Middle East Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Middle East Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 82. Middle East Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 83. Middle East Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Africa Biological & Medical Imaging Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Africa Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Africa Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 87. Africa Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 88. Africa Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Global Biological & Medical Imaging Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. ASEAN Biological & Medical Imaging Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. ASEAN Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. ASEAN Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 93. ASEAN Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 94. ASEAN Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. GCC Biological & Medical Imaging Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. GCC Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. GCC Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 98. GCC Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 99. GCC Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. European Union Biological & Medical Imaging Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. European Union Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. European Union Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 103. European Union Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 104. European Union Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. BRICS Biological & Medical Imaging Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. BRICS Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. BRICS Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 108. BRICS Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 109. BRICS Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. G7 Biological & Medical Imaging Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. G7 Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. G7 Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 113. G7 Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 114. G7 Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. NATO Biological & Medical Imaging Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. NATO Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. NATO Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 118. NATO Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 119. NATO Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Global Biological & Medical Imaging Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. United States Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 122. United States Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 123. United States Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 124. United States Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 125. United States Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Canada Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 127. Canada Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. Canada Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 129. Canada Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 130. Canada Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Mexico Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 132. Mexico Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. Mexico Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 134. Mexico Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 135. Mexico Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Brazil Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 137. Brazil Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. Brazil Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 139. Brazil Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 140. Brazil Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. United Kingdom Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 142. United Kingdom Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. United Kingdom Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 144. United Kingdom Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 145. United Kingdom Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Germany Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 147. Germany Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. Germany Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 149. Germany Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 150. Germany Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. France Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 152. France Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. France Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 154. France Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 155. France Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Russia Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 157. Russia Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. Russia Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 159. Russia Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 160. Russia Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Italy Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 162. Italy Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Italy Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 164. Italy Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 165. Italy Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Spain Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 167. Spain Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Spain Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 169. Spain Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 170. Spain Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. China Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 172. China Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. China Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 174. China Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 175. China Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. India Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 177. India Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. India Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 179. India Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 180. India Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Japan Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 182. Japan Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Japan Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 184. Japan Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 185. Japan Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Australia Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 187. Australia Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. Australia Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 189. Australia Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 190. Australia Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. South Korea Biological & Medical Imaging Reagents Market Size, 2017-2032 (USD Million)
TABLE 192. South Korea Biological & Medical Imaging Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. South Korea Biological & Medical Imaging Reagents Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 194. South Korea Biological & Medical Imaging Reagents Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 195. South Korea Biological & Medical Imaging Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Global Biological & Medical Imaging Reagents Market Share, by Key Player, 2025
TABLE 197. Global Biological & Medical Imaging Reagents Market, Key Experts

Companies Mentioned

  • Agilent Technologies, Inc.
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Bracco Imaging S.p.A.
  • Cardinal Health, Inc.
  • Curium Pharma
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Guerbet Group
  • Jubilant Radiopharma Limited
  • Lantheus Holdings, Inc.
  • Mallinckrodt Pharmaceuticals
  • Merck KGaA
  • PerkinElmer, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Near Infrared Imaging in Healthcare Market - Global Forecast 2026-2032 - Product Image

Near Infrared Imaging in Healthcare Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Biological and Medical Imaging Reagents: Global Markets - Product Image

Biological and Medical Imaging Reagents: Global Markets

  • Report
  • 192 Pages
  • Global
From
IVIS Imaging Systems Market - Global Forecast 2026-2032 - Product Image

IVIS Imaging Systems Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Bio-imaging Market - Global Forecast 2026-2032 - Product Image

Bio-imaging Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031 - Product Image

Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031

  • Report
  • 209 Pages
  • Europe
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.